Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Hypoxia Inducible Factor 1á (HIF-1á) Regulates CD20 Expression in Lymphoma Cells: Possible Implications for Rituximab Based Therapy in Diffuse Large B Cell Lymphoma (DLBCL).

Sairah Ahmed, MD, Andrew M. Evens, DO, MSc, Savita Bhalla, PhD, Amareshwar Singh, PhD, Crystal James, Shuo Yang, PhD, Sheila Prachand, Danijela Dokic, MD, Randy D. Gascoyne, MD, Jane N. Winter, MD, Paul T Schumacker, PhD, Leo I. Gordon, MD

Blood (2009) 114 (22): 1698.

https://doi.org/10.1182/blood.V114.22.1698.1698

Published: 2009

Journal Articles

PX-478, a Novel Small Molecule Inhibitor of Hypoxia Inducible Factor-1 (HIF-1) Downregulates HIF and Induces Cytotoxicity in Diffuse Large B Cell Lymphoma Cells.

Savita Bhalla, PhD, Leo I. Gordon, MD, Amareshwar Singh, PhD, Sairah Ahmed, MD, Danijela Dokic, MD, Crystal James, Paul T Schumacker, PhD, Andrew M Evens, DO, MSc

Blood (2009) 114 (22): 2713.

https://doi.org/10.1182/blood.V114.22.2713.2713

Published: 2009

Journal Articles

Expression of Hypoxia-Inducible Factor (HIF) Is An Independent Favorable Prognostic Factor in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

Andrew M. Evens, DO, MS, Laurie H. Sehn, MD, MPH, Pedro Farinha, MD, Paul T Schumacker, PhD, Adekunle Raji, MS, Yi Lu, MD, Beverly P. Nelson, MD, Randy D. Gascoyne, MD, Leo I. Gordon, MD

Blood (2008) 112 (11): 479.

https://doi.org/10.1182/blood.V112.11.479.479

Published: 2008

Journal Articles

Hypoxia-Inducible Factor-Alpha (HIF-α) Activation in Non-Hodgkin’s Lymphoma (NHL): Relationship to the Thioredoxin Family and Correlation with Survival by Tissue Microarray (TMA).

Andrew M. Evens, DO, MS, Paul T. Schumacker, PhD, Irene B. Helenowski, MS, Amar Singh, PhD, Danijela Dokic, MD, Anjeni Keswani, MD, Elizabeth Kordeluk, BS, Adekunle Raji, MS, Jane N. Winter, MD, Borko D. Jovanovic, PhD, Arne Holmgren, MD, PhD, Beverly P. Nelson, MD, Leo I. Gordon, MD

Blood (2007) 110 (11): 3587.

https://doi.org/10.1182/blood.V110.11.3587.3587

Published: 2007

Journal Articles

Arsenic Trioxide (As 2 O 3 ) Mediated Cell Death in Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL): Investigation of Reactive Oxygen Species (ROS), Caspase, and MAP Kinase Signaling Pathways.

Savita Bhalla, PhD, Amareshwar T.K Singh, PhD, Sheila Prachand, MS, Qudsia Haque, BS, Thomas V. O’Halloran, PhD, Jane N. Winter, MD, Paul T. Schumacker, PhD, Leonidas C. Platanias, MD, Leo I. Gordon, MD, Andrew M. Evens, DO, MS

Blood (2007) 110 (11): 2576.

https://doi.org/10.1182/blood.V110.11.2576.2576

Published: 2007

NARROW

Hypoxia Inducible Factor 1á (HIF-1á) Regulates CD20 Expression in Lymphoma Cells: Possible Implications for Rituximab Based Therapy in Diffuse Large B Cell Lymphoma (DLBCL).

PX-478, a Novel Small Molecule Inhibitor of Hypoxia Inducible Factor-1 (HIF-1) Downregulates HIF and Induces Cytotoxicity in Diffuse Large B Cell Lymphoma Cells.

Expression of Hypoxia-Inducible Factor (HIF) Is An Independent Favorable Prognostic Factor in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

Hypoxia-Inducible Factor-Alpha (HIF-α) Activation in Non-Hodgkin’s Lymphoma (NHL): Relationship to the Thioredoxin Family and Correlation with Survival by Tissue Microarray (TMA).

Arsenic Trioxide (As 2 O 3 ) Mediated Cell Death in Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL): Investigation of Reactive Oxygen Species (ROS), Caspase, and MAP Kinase Signaling Pathways.

Email alerts

ASH Publications

American Society of Hematology

Hypoxia Inducible Factor 1á (HIF-1á) Regulates CD20 Expression in Lymphoma Cells: Possible Implications for Rituximab Based Therapy in Diffuse Large B Cell Lymphoma (DLBCL).

PX-478, a Novel Small Molecule Inhibitor of Hypoxia Inducible Factor-1 (HIF-1) Downregulates HIF and Induces Cytotoxicity in Diffuse Large B Cell Lymphoma Cells.

Expression of Hypoxia-Inducible Factor (HIF) Is An Independent Favorable Prognostic Factor in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

Hypoxia-Inducible Factor-Alpha (HIF-α) Activation in Non-Hodgkin’s Lymphoma (NHL): Relationship to the Thioredoxin Family and Correlation with Survival by Tissue Microarray (TMA).

Arsenic Trioxide (As 2 O 3 ) Mediated Cell Death in Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL): Investigation of Reactive Oxygen Species (ROS), Caspase, and MAP Kinase Signaling Pathways.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only